CYP19A1 and obesity due to melanocortin 4 receptor deficiency: Recently, a case-control study on associations between CYP19A1 polymorphisms and obesity in Turkish population illustrated that the reduced aromatase activity is a risk factor for obesity, and CYP19A1 is associated with hyperandrogenism which may play a role in abdominal obesity pathogenesis [12].